University of Michigan Comprehensive Cancer Center faculty receive many awards and honors. Here are some of their most recent accomplishments.
This issue features three patient stories about clinical trials: two immunotherapy and one precision medicine. It also covers Vice President Joe Biden's cancer moonshot and information about symptom management and alternative/complementary therapy.
In a survey of high-achieving physician-scientists, nearly a third of women reported experiencing sexual harassment.
A new paper looks at how MRI and a clear understanding of the functional anatomy around the prostate can allow radiation oncologists to plan a course of treatment for patients with prostate cancer that spares these critical structures.
An international collaboration newly identify several genes that drive adrenal cancer. In fact, the analysis uncovered double the number of genetic drivers already known to fuel adrenal cancer.
A new device developed by researchers at University of Michigan could provide a non-invasive way to monitor the progress of an advanced cancer treatment.
An increase in women with breast cancer choosing double mastectomy may be influenced by media coverage of celebrities, a new study finds.
Most cancer drugs today work by attacking tumor growth. Researchers at the University of Michigan Life Sciences Institute, however, are taking aim at a different piece of the cancer puzzle -- preventing its ability to spread to new parts of the body, known as metastasis, which is the cause of most cancer deaths.
University of Michigan Comprehensive Cancer Center experts will discuss breast cancer risks (and how you can reduce yours), as well as screening, treatment and research at a free Breast Cancer Summit on Saturday, April 9, at the University of Michigan North Campus Research Complex.
A new study finds most cancer screening guidelines do not clearly spell out the benefits and harms of the recommended actions.